• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Independence Blue Cross Latest Name Added to the White House Healthcare AI Commitments


A total of 37 payers and providers have now signed on.

AI doctor © Production Perig - stock.adobe.com

AI doctor © Production Perig - stock.adobe.com

Artificial intelligence use in healthcare is on the rise in the United States. To ensure it remains safe, secure and trustworthy, the White House drafted a pledge called the White House Healthcare AI Commitments, originally published on Dec. 14, 2023.

Since then, 37 payers and providers have shown solidarity with the following five official statements:

  1. We commit to vigorously developing AI solutions to optimize healthcare delivery and payment by advancing health equity, expanding access, making healthcare more affordable, importing outcomes through more coordinated care, improving patient experience, and reducing clinician burnout.
  2. We will work with our peers and partners to ensure outcomes are aligned with fair, appropriate, valid, effective, and safe (FAVES) AI principals.
  3. We will deploy trust mechanisms that inform users if the content is largely AI-generated and not reviewed or edited by a human.
  4. We will adhere to a risk management framework that includes comprehensive tracking of applications powered by frontier models and accounts for potential harms and steps to mitigate them.
  5. We will research, investigate, and develop swiftly but will do so responsibly.

As of yesterday, Independence Blue Cross (IBX) is the latest organization to add its name to the list.

“Independence Blue Cross continues to lead the way in health care innovation. We are dedicated to advocating for advancements that improve care delivery, user experience, and affordability,” Mike Vennera, executive vice president and chief strategy, development, and information officer for Independence Blue Cross said in a news release. “We’re proud to have a seat at the table, among other policy experts and national thought leaders.”

Other notable names on the list include CVS Health, Tufts Medicine, Boston Children's Hospital, Duke Health, UC Davis Health, Allina Health and Ceders-Sinai.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Related Content
© 2024 MJH Life Sciences

All rights reserved.